Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease

par Yilin Cao, Hanbo Chen, Arjun Sahgal, Darby Erler, Serena Badellino, Tithi Biswas, Roi Dagan, Matthew C. Foote, Alexander V. Louie, Ian Poon, Umberto Ricardi, Kristin J. Redmond
Publié 2021

SABR in oligometastatic breast cancer: Current status and future directions

par Rachel Stewart, Michelle White, Jennifer Tan, Shankar Siva, Lama Karroum, Steven David
Publié 2021

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer

par Kristin A. Plichta, Stephen A. Graves, John M. Buatti
Publié 2021

Oligometastatic non-small-cell lung cancer: current treatment strategies

par Richard PJ, Rengan R
Publié 2016

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer

par Danyang Zhou, Kuikui Jiang, Ruoxi Hong, Qianyi Lu, Wen Xia, Mei Li, Chengyou Zheng, Qiufan Zheng, Fei Xu, Shusen Wang
Publié 2021

Highlighting the Place of Metastasis-Directed Therapy in Isolated Liver Metastases in Prostate Cancer: A Case Report

par Anne-Emmanuella Yeo, Aurore Hendrix, Caterina Confente, Nicolas Christian, Baudouin Mansvelt, Géraldine Pairet, Emmanuel Seront
Publié 2021

Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer

par David L. Billing, Andreas Rimner
Publié 2021

[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer

par Martina Sollini, Francesco Bartoli, Lara Cavinato, Francesca Ieva, Alessandra Ragni, Andrea Marciano, Roberta Zanca, Luca Galli, Fabiola Paiar, Francesco Pasqualetti, Paola Anna Erba
Publié 2021

Oligoprogression in Non-Small Cell Lung Cancer

par Daijiro Harada, Nagio Takigawa
Publié 2021